Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study consists of a single-dose pilot phase and a randomized, two-way crossover,
single-dose main phase.The aim of this study is to evaluate the absolute bioavailability of
the oral formulation (tablet) of ponesimod compared to an intravenous (i.v.) ponesimod
formulation. Three subjects will be included in the pilot phase and 12 subjects in the main
crossover phase.